|
|
| | CLADRIBINE RELATED COMPOUND A (20 MG) (2-METHOXY-2'-DEOXYADENOSINE) Basic information |
| Product Name: | CLADRIBINE RELATED COMPOUND A (20 MG) (2-METHOXY-2'-DEOXYADENOSINE) | | Synonyms: | Cladribine EP Impurity B;(2R,3S,5R)-5-(6-amino-2-methoxypurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;CLADRIBINE RELATED COMPOUND A (20 MG) (2-METHOXY-2'-DEOXYADENOSINE);9-(2-Deoxy-beta-D-ribofuranosyl)-2-methoxyadenine;Cladribine USP Related Compound A;2-Methoxy-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine;Cladribine Impurity 2(Cladribine EP Impurity B);Adenosine, 2'-deoxy-2-methoxy- (8CI,9CI) | | CAS: | 24757-70-8 | | MF: | C11H15N5O4 | | MW: | 281.27 | | EINECS: | | | Product Categories: | | | Mol File: | 24757-70-8.mol |  |
| | CLADRIBINE RELATED COMPOUND A (20 MG) (2-METHOXY-2'-DEOXYADENOSINE) Chemical Properties |
| Boiling point | 659.1±65.0 °C(Predicted) | | density | 1.84±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 13.77±0.60(Predicted) | | form | Solid | | color | White to Off-White | | Stability: | Hygroscopic | | Major Application | pharmaceutical (small molecule) | | InChI | 1S/C11H15N5O4/c1-19-11-14-9(12)8-10(15-11)16(4-13-8)7-2-5(18)6(3-17)20-7/h4-7,17-18H,2-3H2,1H3,(H2,12,14,15) | | InChIKey | HGRICISHTIAZJG-UHFFFAOYSA-N | | SMILES | [n]2(c3nc(nc(c3nc2)N)OC)C1OC(C(C1)O)CO |
| WGK Germany | 3 | | HS Code | 2934990002 | | Storage Class | 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects | | Hazard Classifications | Acute Tox. 3 Oral
Muta. 2
Repr. 2
STOT RE 1 |
| | CLADRIBINE RELATED COMPOUND A (20 MG) (2-METHOXY-2'-DEOXYADENOSINE) Usage And Synthesis |
| Uses | 2-Methoxy-2''-deoxyadenosine is an impurity in the synthesis of Cladribine (M262330), a substituted purine nucleoside with antileukemic activity. |
| | CLADRIBINE RELATED COMPOUND A (20 MG) (2-METHOXY-2'-DEOXYADENOSINE) Preparation Products And Raw materials |
|